| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0889-8545(05)70296-5 |
| P698 | PubMed publication ID | 9086525 |
| P2093 | author name string | Evans MI | |
| Johnson MP | |||
| Yaron Y | |||
| Kramer RL | |||
| P2860 | cites work | Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients | Q72656870 |
| A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia | Q28291035 | ||
| Lethal alpha-thalassaemia created by gene targeting in mice and its genetic rescue | Q28512349 | ||
| Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats | Q34209312 | ||
| Intracellular antibodies as a new class of therapeutic molecules for gene therapy | Q34322680 | ||
| Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans | Q34345458 | ||
| Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction | Q34354588 | ||
| Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency | Q34454454 | ||
| In vivo cytokine gene transfer by gene gun reduces tumor growth in mice | Q34513704 | ||
| Combination anti-gene therapy targeting c-myc and p53 in ovarian cancer cell lines | Q38291031 | ||
| Cell and gene therapy in Duchenne muscular dystrophy | Q40389099 | ||
| Gene therapy for the respiratory manifestations of cystic fibrosis | Q40398397 | ||
| Delivery of DNA into mammalian cells by receptor-mediated endocytosis and gene therapy. | Q40409746 | ||
| The challenge of fetal gene therapy | Q40429935 | ||
| Myoblast transfer and gene therapy in muscular dystrophies | Q40437473 | ||
| Receptor-mediated DNA delivery approaches to human gene therapy. | Q40449701 | ||
| Gene targeting in mammalian cells by homologous recombination | Q40533915 | ||
| Non-viral approaches to gene therapy. | Q40534145 | ||
| Site-specific recombination: developments and applications | Q40535474 | ||
| Non-viral gene therapy | Q40535778 | ||
| Metabolic suicide genes in gene therapy | Q40561774 | ||
| Germ-line gene modification and disease prevention: some medical and ethical perspectives | Q40766906 | ||
| Correction of deficient enzyme activity in a lysosomal storage disease, aspartylglucosaminuria, by enzyme replacement and retroviral gene transfer | Q40984951 | ||
| p53 Trans-Dominantly Suppresses Tumor Formation of Human Breast Cancer Cells Mediated by Retroviral Bulk Infection without Marker Gene Selection: An Expeditious In Vitro Protocol with Implications towards Gene Therapy | Q40990697 | ||
| Preimplantation genetics: a case for prospective action | Q41022406 | ||
| Therapeutic gene delivery in human B-lymphoblastoid cells by engineered non-transforming infectious Epstein-Barr virus | Q41268850 | ||
| A new cationic liposome encapsulating genetic material. A potential delivery system for polynucleotides | Q41359935 | ||
| Correction of the cystic fibrosis defect by gene complementation in human intrahepatic biliary epithelial cell lines | Q41378195 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Safety and toxicity of catheter gene delivery to the pulmonary vasculature in a patient with metastatic melanoma | Q42488361 | ||
| Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase | Q43185222 | ||
| Selection of gene-marked tumor infiltrating lymphocytes from post-treatment biopsies: a case study | Q45022447 | ||
| Circulating human factor IX produced in keratin-promoter transgenic mice: a feasibility study for gene therapy of haemophilia B. | Q45866581 | ||
| Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients | Q45866834 | ||
| T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. | Q45866838 | ||
| The feasibility of targeted selective gene therapy of the hair follicle | Q45867425 | ||
| Development of ribozymes for gene therapy. | Q45871224 | ||
| An early history of gene transfer and therapy | Q45871916 | ||
| Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia | Q45871954 | ||
| Insulin delivery by somatic cell gene therapy | Q45872665 | ||
| Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy | Q45873048 | ||
| Debunking the slippery slope argument against human germ-line gene therapy | Q45873160 | ||
| Lymphocyte gene therapy | Q45881517 | ||
| Ethical issues in genetic therapy. | Q53661088 | ||
| Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis | Q57416213 | ||
| Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene | Q64377654 | ||
| Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice | Q64377665 | ||
| Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors | Q70801531 | ||
| Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis | Q71660966 | ||
| Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro | Q71803471 | ||
| P433 | issue | 1 | |
| P921 | main subject | gene therapy | Q213901 |
| P304 | page(s) | 179-199 | |
| P577 | publication date | 1997-03-01 | |
| P1433 | published in | Obstetrics and Gynecology Clinics of North America | Q15750118 |
| P1476 | title | Gene therapy. Is the future here yet? | |
| P478 | volume | 24 |
Search more.